Niedrobnokomórkowy rak płuca: badanie fazy III leku pembrolizumab i nivolumab
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS…